Medications for Pain Measurement

16 results
  • PharmaForce, Inc.
    Usage: Clonidine hydrochloride is indicated for use with opiates to treat severe cancer-related pain not sufficiently managed by opioids alone. It is particularly effective for neuropathic pain. Safety is established only in selected cancer patients after opioid trials; other uses are not recommended due to unproven safety.
  • Padagis US LLC
    Usage: Hydromorphone hydrochloride extended-release tablets are indicated for managing severe, persistent pain requiring long-term opioid treatment when alternatives are inadequate. They are for opioid-tolerant patients only and are not intended for as-needed use due to risks of addiction and overdose.
  • Major Pharmaceuticals
    Usage: Methadone Hydrochloride Tablets are indicated for managing severe pain requiring long-term opioid treatment and for detoxification and maintenance treatment of opioid addiction. It should be used when alternative analgesics are inadequate or poorly tolerated. Not for as-needed use.
  • Hikma Pharmaceuticals USA Inc.
    Usage: Methadone Hydrochloride Oral Solution is indicated for managing severe and persistent pain requiring long-term opioid treatment, and for detoxification and maintenance of opioid addiction. It should be reserved for patients not responding to alternative treatments. It is not intended for as-needed use.
  • Aurolife Pharma, LLC
    Usage: Methadone Hydrochloride Tablets are indicated for managing severe, persistent pain requiring long-term opioid treatment when other options are inadequate, and for detoxification and maintenance treatment of opioid addiction. They are not meant for as-needed use and have specific distribution requirements for addiction treatment.
  • Bryant Ranch Prepack
    Usage: Methadone hydrochloride tablets are indicated for managing severe, persistent pain requiring long-term opioid treatment and for detoxification and maintenance of opioid addiction. They should be reserved for patients where alternative treatments are ineffective, and are not meant for as-needed use.
  • Lupin Pharmaceuticals Inc
    Usage: Morphine sulfate extended-release tablets are indicated for managing severe, persistent pain requiring long-term opioid treatment when other options are inadequate. It is not intended for as-needed use and carries risks of addiction, abuse, and overdose, necessitating careful patient selection.
  • Hospira, Inc.
    Usage: Morphine sulfate is indicated for severe pain relief, preoperative sedation, and post-operative pain management. It's used in conditions like myocardial infarction, severe injuries, and terminal cancer pain when non-narcotic analgesics fail. Additionally, it aids in alleviating anxiety and dyspnea associated with acute left ventricular and pulmonary edema.
  • Nortec Development Associates, Inc.
    Usage: Morphine Sulfate Extended-Release Capsules are indicated for managing severe, persistent pain requiring long-term opioid treatment when alternative options are inadequate. They should be reserved for patients not responding to other analgesics and are not intended for as-needed use due to risks of addiction and overdose.
  • ATLANTIC BIOLOGICALS CORP.
    Usage: Morphine sulfate solution is indicated for the relief of moderate to severe acute and chronic pain in opioid-tolerant patients. It is an opioid analgesic suitable where opioid use is appropriate, with specific dosages available for oral administration. Caution is required due to risks of respiratory depression in opioid-naive patients.